Parametric Portfolio Associates’s Dermira, Inc. DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-24,187
Closed -$367K 4063
2019
Q4
$367K Sell
24,187
-908
-4% -$7.84K ﹤0.01% 3491
2019
Q3
$160K Sell
25,095
-12,198
-33% -$102K ﹤0.01% 3760
2019
Q2
$357K Sell
37,293
-103,234
-73% -$1.11M ﹤0.01% 3507
2019
Q1
$1.9M Buy
140,527
+58,036
+70% +$484K ﹤0.01% 2694
2018
Q4
$593K Sell
82,491
-24,932
-23% -$273K ﹤0.01% 3233
2018
Q3
$1.17M Sell
107,423
-3,284
-3% -$33.1K ﹤0.01% 3002
2018
Q2
$1.02M Buy
110,707
+81,992
+286% +$764K ﹤0.01% 3052
2018
Q1
$229K Sell
28,715
-7,968
-22% -$173K ﹤0.01% 3711
2017
Q4
$1.02M Buy
36,683
+13,120
+56% +$348K ﹤0.01% 3013
2017
Q3
$636K Sell
23,563
-8,305
-26% -$217K ﹤0.01% 3293
2017
Q2
$929K Buy
31,868
+11,437
+56% +$348K ﹤0.01% 3029
2017
Q1
$697K Buy
20,431
+4,417
+28% +$143K ﹤0.01% 3041
2016
Q4
$486K Sell
16,014
-23,338
-59% -$752K ﹤0.01% 3208
2016
Q3
$1.33M Buy
39,352
+25,004
+174% +$805K ﹤0.01% 2623
2016
Q2
$420K Buy
+14,348
New +$396K ﹤0.01% 3286

Parametric Portfolio Associates's DERM Position: Q1 2020 in Review

Parametric Portfolio Associates sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 24,187 shares — an estimated $367K sold.

Parametric Portfolio Associates first reported a position in DERM in Q2 2016 and held it in 15 quarters. The position peaked at $1.9M in Q1 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

  • Parametric Portfolio Associates reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 24,187 Dermira, Inc. shares in Q1 2020, an estimated $367K.
  • Parametric Portfolio Associates first reported a position in Dermira, Inc. in Q2 2016 and held it in 15 quarters.
  • Parametric Portfolio Associates's Dermira, Inc. position peaked at $1.9M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Parametric Portfolio Associates's 13F filing for Q1 2020, filed 13 May 2020.